BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 34555265)

  • 1. Effects of ApoE genotype on clinical phenotypes in early-onset and late-onset Alzheimer's disease in China: Data from the PUMCH dementia cohort.
    Dong L; Li J; Liu C; Mao C; Wang J; Lei D; Huang X; Chu S; Hou B; Feng F; Sha L; Xu Q; Gao J
    Brain Behav; 2021 Nov; 11(11):e2373. PubMed ID: 34555265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the APOEɛ4 Allele on the Relationship Between Tau and Amyloid-β in Early- and Late-Onset Alzheimer's Disease.
    Kang JM; Shin JH; Kim WR; Seo S; Seo H; Lee SY; Park KH; Na DL; Okamura N; Seong JK; Noh Y
    J Alzheimers Dis; 2023; 94(3):1233-1246. PubMed ID: 37393505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The APOE4 effect: structural brain differences in Alzheimer's disease according to the age at symptom onset.
    Forno G; Contador J; Pérez-Millan A; Guillen N; Falgàs N; Sarto J; Tort-Merino A; Castellví M; Bosch B; Fernández-Villullas G; Balasa M; Antonell A; Sala-Llonch R; Sanchez-Valle R; Hornberger M; Lladó A
    Eur J Neurol; 2023 Mar; 30(3):597-605. PubMed ID: 36463489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
    Mandecka M; Budziszewska M; Barczak A; Pepłońska B; Chodakowska-Żebrowska M; Filipek-Gliszczyńska A; Nesteruk M; Styczyńska M; Barcikowska M; Gabryelewicz T
    J Alzheimers Dis; 2016 Jul; 54(1):157-68. PubMed ID: 27472875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APOE ε4 carrier status and sex differentiate rates of cognitive decline in early- and late-onset Alzheimer's disease.
    Polsinelli AJ; Logan PE; Lane KA; Manchella MK; Nemes S; Sanjay AB; Gao S; Apostolova LG
    Alzheimers Dement; 2023 May; 19(5):1983-1993. PubMed ID: 36394443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Apolipoprotein E ɛ4 Allele With Clinical and Multimodal Biomarker Changes of Alzheimer Disease in Adults With Down Syndrome.
    Bejanin A; Iulita MF; Vilaplana E; Carmona-Iragui M; Benejam B; Videla L; Barroeta I; Fernandez S; Altuna M; Pegueroles J; Montal V; Valldeneu S; Giménez S; González-Ortiz S; Muñoz L; Padilla C; Aranha MR; Estellés T; Illán-Gala I; Belbin O; Camacho V; Wilson LR; Annus T; Osorio RS; Videla S; Lehmann S; Holland AJ; Zetterberg H; Blennow K; Alcolea D; Clarimon J; Zaman SH; Blesa R; Lleó A; Fortea J
    JAMA Neurol; 2021 Aug; 78(8):937-947. PubMed ID: 34228042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APOE ε4 is associated with earlier symptom onset in LOAD but later symptom onset in EOAD.
    Polsinelli AJ; Lane KA; Manchella MK; Logan PE; Gao S; Apostolova LG
    Alzheimers Dement; 2023 May; 19(5):2212-2217. PubMed ID: 36722399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex and APOE ε4 carrier effects on atrophy, amyloid PET, and tau PET burden in early-onset Alzheimer's disease.
    Nemes S; Logan PE; Manchella MK; Mundada NS; La Joie R; Polsinelli AJ; Hammers DB; Koeppe RA; Foroud TM; Nudelman KN; Eloyan A; Iaccarino L; Dorsant-Ardón V; Taurone A; Thangarajah M; Dage JL; Aisen P; Grinberg LT; Jack CR; Kramer J; Kukull WA; Murray ME; Rumbaugh M; Soleimani-Meigooni DN; Toga A; Touroutoglou A; Vemuri P; Atri A; Day GS; Duara R; Graff-Radford NR; Honig LS; Jones DT; Masdeu J; Mendez MF; Musiek E; Onyike CU; Riddle M; Rogalski E; Salloway S; Sha SJ; Turner RS; Wingo TS; Womack KB; Wolk DA; Rabinovici GD; Carrillo MC; Dickerson BC; Apostolova LG;
    Alzheimers Dement; 2023 Nov; 19 Suppl 9(Suppl 9):S49-S63. PubMed ID: 37496307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional study.
    Boerwinkle AH; Gordon BA; Wisch J; Flores S; Henson RL; Butt OH; McKay N; Chen CD; Benzinger TLS; Fagan AM; Handen BL; Christian BT; Head E; Mapstone M; Rafii MS; O'Bryant S; Lai F; Rosas HD; Lee JH; Silverman W; Brickman AM; Chhatwal JP; Cruchaga C; Perrin RJ; Xiong C; Hassenstab J; McDade E; Bateman RJ; Ances BM; ;
    Lancet Neurol; 2023 Jan; 22(1):55-65. PubMed ID: 36517172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A genetic screen of the mutations in the Korean patients with early-onset Alzheimer's disease.
    An SS; Park SA; Bagyinszky E; Bae SO; Kim YJ; Im JY; Park KW; Park KH; Kim EJ; Jeong JH; Kim JH; Han HJ; Choi SH; Kim S
    Clin Interv Aging; 2016; 11():1817-1822. PubMed ID: 28008242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Common Variants of APOE, ABCA7, A2M, BACE1, and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease: Data from the PUMCH Dementia Cohort.
    Dong L; Mao C; Liu C; Li J; Huang X; Wang J; Lei D; Chu S; Sha L; Xu Q; Peng B; Cui L; Gao J
    J Alzheimers Dis; 2022; 85(4):1511-1518. PubMed ID: 34958020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E epsilon4 allele differently affects the patterns of neuropsychological presentation in early- and late-onset Alzheimer's disease patients.
    Marra C; Bizzarro A; Daniele A; De Luca L; Ferraccioli M; Valenza A; Brahe C; Tiziano FD; Gainotti G; Masullo C
    Dement Geriatr Cogn Disord; 2004; 18(2):125-31. PubMed ID: 15211066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of APOE genotype on the delivery of DHA to cerebrospinal fluid in Alzheimer's disease.
    Yassine HN; Rawat V; Mack WJ; Quinn JF; Yurko-Mauro K; Bailey-Hall E; Aisen PS; Chui HC; Schneider LS
    Alzheimers Res Ther; 2016 Jun; 8():25. PubMed ID: 27358067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PICALM Variation Moderates the Relationships of APOE ɛ4 with Alzheimer's Disease Cerebrospinal Biomarkers and Memory Function Among Non-Demented Population.
    Liu YB; Wang XJ; Tan L; Tan CC; Xu W;
    J Alzheimers Dis; 2023; 96(4):1651-1661. PubMed ID: 38007652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study.
    Reiman EM; Quiroz YT; Fleisher AS; Chen K; Velez-Pardo C; Jimenez-Del-Rio M; Fagan AM; Shah AR; Alvarez S; Arbelaez A; Giraldo M; Acosta-Baena N; Sperling RA; Dickerson B; Stern CE; Tirado V; Munoz C; Reiman RA; Huentelman MJ; Alexander GE; Langbaum JB; Kosik KS; Tariot PN; Lopera F
    Lancet Neurol; 2012 Dec; 11(12):1048-56. PubMed ID: 23137948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Genetics of Early- and Late-Onset Alzheimer's Disease.
    Uddin MS; Hasana S; Hossain MF; Islam MS; Behl T; Perveen A; Hafeez A; Ashraf GM
    Curr Gene Ther; 2021; 21(1):43-52. PubMed ID: 33231156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of
    Shang L; Dong L; Huang X; Wang T; Mao C; Li J; Wang J; Liu C; Gao J
    Front Aging Neurosci; 2023; 15():1119070. PubMed ID: 37065463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profiling baseline performance on the Longitudinal Early-Onset Alzheimer's Disease Study (LEADS) cohort near the midpoint of data collection.
    Hammers DB; Eloyan A; Taurone A; Thangarajah M; Beckett L; Gao S; Kirby K; Aisen P; Dage JL; Foroud T; Griffin P; Grinberg LT; Jack CR; Kramer J; Koeppe R; Kukull WA; Mundada NS; La Joie R; Soleimani-Meigooni DN; Iaccarino L; Murray ME; Nudelman K; Polsinelli AJ; Rumbaugh M; Toga A; Touroutoglou A; Vemuri P; Atri A; Day GS; Duara R; Graff-Radford NR; Honig LS; Jones DT; Masdeu J; Mendez MF; Womack K; Musiek E; Onyike CU; Riddle M; Rogalski E; Salloway S; Sha SJ; Turner RS; Wingo TS; Wolk DA; Carrillo MC; Dickerson BC; Rabinovici GD; Apostolova LG;
    Alzheimers Dement; 2023 Nov; 19 Suppl 9(Suppl 9):S8-S18. PubMed ID: 37256497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic interaction between ApoE genotype and onset age in Alzheimer's disease: implications for brain reserve.
    Mosconi L; Herholz K; Prohovnik I; Nacmias B; De Cristofaro MT; Fayyaz M; Bracco L; Sorbi S; Pupi A
    J Neurol Neurosurg Psychiatry; 2005 Jan; 76(1):15-23. PubMed ID: 15607989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive profiles and neuropsychiatric symptoms in Korean early-onset Alzheimer's disease patients: a CREDOS study.
    Park HK; Choi SH; Park SA; Kim HJ; Lee Y; Han SH; Kim EJ; Kim BC; Han HJ; Moon SY; Yang DW; Park KW; Park KH; Yoon B; Seo SW; Na DL; Na HR; Lee JH
    J Alzheimers Dis; 2015; 44(2):661-73. PubMed ID: 25322926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.